Mergim Meta

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Molecular Docking

African American

Atomic Force Microscopy

Top Venues

ACS infectious diseases

International journal of molecular sciences

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Natalie Fuchs, Robert Alexander Zimmermann, Marvin Schwickert, Annika Gunkel, Collin Zimmer, Mergim Meta, Kevin Schwickert, Jennifer Keiser, Cécile Haeberli, Werner Kiefer, Tanja Schirmeister
Dual Strategy to Design New Agents Targeting Schistosoma mansoni : Advancing Phenotypic and Sm CB1 Inhibitors for Improved Efficacy. ACS infectious diseases 10 (5) (2024)
Mergim Meta, Collin Zimmer, Natalie Fuchs, Maximilian Johannes Zecher, Albin Lahu, Tanja Schirmeister
Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability. ACS medicinal chemistry letters 15 (6) (2024)
Natalie Fuchs, Robert Alexander Zimmermann, Marvin Schwickert, Annika Gunkel, Collin Zimmer, Mergim Meta, Kevin Schwickert, Jennifer Keiser, Cécile Haeberli, Werner Kiefer, Tanja Schirmeister
Dual Strategy to Design New Agents Targeting Schistosoma mansoni : Advancing Phenotypic and Sm CB1 Inhibitors for Improved Efficacy. ACS infectious diseases 10 (5) (2024)
Mergim Meta, Collin Zimmer, Natalie Fuchs, Maximilian Johannes Zecher, Albin Lahu, Tanja Schirmeister
Structural Modifications of Covalent Cathepsin S Inhibitors: Impact on Affinity, Selectivity, and Permeability. ACS medicinal chemistry letters 15 (6) (2024)
Natalie Fuchs, Robert Alexander Zimmermann, Marvin Schwickert, Annika Gunkel, Collin Zimmer, Mergim Meta, Kevin Schwickert, Jennifer Keiser, Cécile Haeberli, Werner Kiefer, Tanja Schirmeister
Dual Strategy to Design New Agents Targeting Schistosoma mansoni : Advancing Phenotypic and Sm CB1 Inhibitors for Improved Efficacy. ACS infectious diseases (2024)
Natalie Fuchs, Robert Alexander Zimmermann, Marvin Schwickert, Annika Gunkel, Collin Zimmer, Mergim Meta, Kevin Schwickert, Jennifer Keiser, Cécile Haeberli, Werner Kiefer, Tanja Schirmeister
Dual Strategy to Design New Agents Targeting Schistosoma mansoni : Advancing Phenotypic and Sm CB1 Inhibitors for Improved Efficacy. ACS infectious diseases 10 (5) (2024)
Patrick Müller, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten, Collin Zimmer, Stefan Josef Hammerschmidt, Ariane Frey, Albin Lahu, Sergio de la Hoz-Rodríguez, Laura Agost-Beltrán, Santiago Rodríguez, Kira Diemer, Wilhelm Neumann, Florenci V González, Bernd Engels, Tanja Schirmeister
Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors-A Comprehensive Reactivity and Selectivity Study. International journal of molecular sciences 24 (8) (2023)
Patrick Müller, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten, Collin Zimmer, Stefan Josef Hammerschmidt, Ariane Frey, Albin Lahu, Sergio de la Hoz-Rodríguez, Laura Agost-Beltrán, Santiago Rodríguez, Kira Diemer, Wilhelm Neumann, Florenci V González, Bernd Engels, Tanja Schirmeister
Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors-A Comprehensive Reactivity and Selectivity Study. International journal of molecular sciences 24 (8) (2023)
Patrick Müller, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten, Collin Zimmer, Stefan Josef Hammerschmidt, Ariane Frey, Albin Lahu, Sergio de la Hoz-Rodríguez, Laura Agost-Beltrán, Santiago Rodríguez, Kira Diemer, Wilhelm Neumann, Florenci V González, Bernd Engels, Tanja Schirmeister
Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors-A Comprehensive Reactivity and Selectivity Study. International journal of molecular sciences 24 (8) (2023)